These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 2918943)
21. Biocompatibility of different hemodialysis and plasmapheresis membranes. Jørstad S Blood Purif; 1987; 5(2-3):123-37. PubMed ID: 3497645 [TBL] [Abstract][Full Text] [Related]
22. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications. Kadiri S; Kehinde Z; Arije A; Salako BL Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127 [TBL] [Abstract][Full Text] [Related]
23. Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis. Thylén P; Lundahl J; Fernvik E; Hed J; Svenson SB; Jacobson SH Am J Nephrol; 1992; 12(6):393-400. PubMed ID: 1292337 [TBL] [Abstract][Full Text] [Related]
24. Symptoms and activation of granulocytes and complement with two dialysis membranes. Ivanovich P; Chenoweth DE; Schmidt R; Klinkmann H; Boxer LA; Jacob HS; Hammerschmidt DE Kidney Int; 1983 Dec; 24(6):758-63. PubMed ID: 6609268 [TBL] [Abstract][Full Text] [Related]
25. Leukotriene release from neutrophils of patients on hemodialysis with cellulose membranes. Jörres A; Jörres D; Gahl GM; Schulz E; Mahiout A Int J Artif Organs; 1992 Feb; 15(2):84-8. PubMed ID: 1313396 [TBL] [Abstract][Full Text] [Related]
26. Synthetically modified cellulose: an alternative to synthetic membranes for use in haemodialysis? Hoenich NA; Woffindin C; Stamp S; Roberts SJ; Turnbull J Biomaterials; 1997 Oct; 18(19):1299-303. PubMed ID: 9307219 [TBL] [Abstract][Full Text] [Related]
27. Compartmental distribution of complement activation products in artificial kidneys. Cheung AK; Chenoweth DE; Otsuka D; Henderson LW Kidney Int; 1986 Jul; 30(1):74-80. PubMed ID: 3489123 [TBL] [Abstract][Full Text] [Related]
29. CD31 expression on leukocytes is downregulated in vivo during hemodialysis. Kawabata K; Nakai S; Miwa M; Sugiura T; Otsuka Y; Shinzato T; Hiki N; Tomimatsu I; Ushida Y; Hosono F; Maeda K Nephron; 2001 Oct; 89(2):153-60. PubMed ID: 11549897 [TBL] [Abstract][Full Text] [Related]
30. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets]. Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z; Cichoń R; Szydłowska I Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988 [TBL] [Abstract][Full Text] [Related]
31. Does an alteration of dialyzer design and geometry affect biocompatibility parameters? Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675 [TBL] [Abstract][Full Text] [Related]
32. The Choice of Hemodialysis Membrane Affects Bisphenol A Levels in Blood. Bosch-Panadero E; Mas S; Sanchez-Ospina D; Camarero V; Pérez-Gómez MV; Saez-Calero I; Abaigar P; Ortiz A; Egido J; González-Parra E J Am Soc Nephrol; 2016 May; 27(5):1566-74. PubMed ID: 26432902 [TBL] [Abstract][Full Text] [Related]
34. Effect of cuprophan, hemophan and polysulfone membranes on the oxidative metabolism, degranulation reaction, enzyme release and pulmonary sequestration of granulocytes. Kolb G; Fischer W; Schoenemann H; Bathke K; Höffken H; Müller T; Lange H; Joseph K; Havemann K Contrib Nephrol; 1989; 74():10-21. PubMed ID: 2562018 [No Abstract] [Full Text] [Related]
35. Apoptotic markers on lymphocytes and monocytes are unchanged during single hemodialysis sessions using either regenerated cellulose or polysulfone membranes. Wu CC; Liao TN; Lu KC; Chen JS; Chu P; Lin SH; Chuang CH; Lin YF Clin Nephrol; 2005 Sep; 64(3):198-204. PubMed ID: 16175944 [TBL] [Abstract][Full Text] [Related]
36. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis. de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797 [TBL] [Abstract][Full Text] [Related]
37. Clinical evaluation of a new high-flux cellulose acetate membrane. Schaefer RM; Huber L; Gilge U; Bausewein K; Vienken J; Heidland A Int J Artif Organs; 1989 Feb; 12(2):85-90. PubMed ID: 2651325 [TBL] [Abstract][Full Text] [Related]
38. In vivo evaluation of platelet activation by different cellulosic membranes. Cases A; Reverter JC; Escolar G; Sanz C; Sorribes J; Ordinas A Artif Organs; 1997 Apr; 21(4):330-4. PubMed ID: 9096808 [TBL] [Abstract][Full Text] [Related]
39. Leukocyte overshoot: a new sign of bioincompatibility in fast hemodialysis. Kjellstrand P; Jacobson SH; Skröder R; Holmquist B; Boberg U; Lins LE; Okmark P; Kjellstrand CM ASAIO Trans; 1990; 36(3):M314-6. PubMed ID: 2252687 [TBL] [Abstract][Full Text] [Related]
40. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis? Mrowka C; Heintz B; Sieberth HG Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]